Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke 8/30/18 Eagle Pharmaceuticals Named to Fortune 100 List of Fastest-Growing Companies 8/23/18 Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA 8/22/18 Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results 8/7/18 Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2018 Financial Results on August 7, 2018 7/25/18 FDA Grants Eagle Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection) 7/9/18 Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA 7/3/18 Court Issues Decision in Favor of Eagle Pharmaceuticals Granting Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection) 6/11/18 Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June 5/29/18 Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml Admixture 5/16/18 Pagination First page Previous page Page 1 Current page 2 Page 3 Next page Last page
